Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Gynecologic 2Classical hematology 1Breast 1

Conditions

Papillomavirus Infections 7Uterine Cervical Neoplasms 5Neuroendocrine Tumors 4Neoplasms 4Autoimmune Diseases 3Ovarian Neoplasms 2Myasthenia Gravis 2Mesothelioma, Malignant 2Lung Neoplasms 2Venous Thrombosis 1Venous Thromboembolism 1Uterine Cervical Dysplasia 1Thyroid Diseases 1Thrombosis 1Squamous Intraepithelial Lesions 1Retinal Telangiectasis 1Renal Insufficiency 1Recurrence 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Hairy Cell 1Hemorrhage 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1

Interventions

Carboplatin 177Paclitaxel 176Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × Data Collection × Clear all
NCT02262273 2017-03-01

OSCA

AstraZeneca

Completed
2,123 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

M.D. Anderson Cancer Center

Completed
176 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡